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ABSTRACT Acquired 16S rRNA methylases (RMTases) conferring pan-drug resis-
tance to aminoglycosides were searched among enterobacterial isolates recovered in
Angola. A total of 36 hospitalized children were screened for rectal colonization us-
ing the Superaminoglycoside selective medium. Twenty-two pan-aminoglycoside-
resistant enterobacterial isolates were recovered, all of which produced RMTases, i.e.,
RmtB, ArmA, and RmtC. Highly diverse genetic backgrounds were identiﬁed for Esch-
erichia coli and Klebsiella pneumoniae isolates, most of which coproduced carbapen-
emases NDM-1 or NDM-5, respectively.
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Aminoglycosides (AGs) play an important role in antimicrobial therapy in severeinfections, usually in combination with -lactam agents. AG resistance usually
arises from modiﬁcation of the AG molecules by various enzymes, namely, phospho-
transferases, adenylyltransferases, nucloetidyltransferases, and acetyltransferases, which
affect some but not all AGs (1). Another mechanism corresponds with the production
of 16S rRNA methylases (RMTases) that are mostly encoded by plasmids and found
among Gram-negative bacteria (1). They methylate the AG binding site in the bacterial
16S RNA ribosomal subunit, leading to loss of interaction between the antibiotic and its
target (1, 2). The recent emergence and spread of genes encoding these RMTases is
worrisome because they are often identiﬁed in isolates that produce extended-
spectrum -lactamases (ESBLs) (3) and carbapenemases, particularly the class B NDM-
like metalloenzymes in the latter case (2, 4). Among the 10 RMTases described so far,
the most widespread are ArmA and RmtB (1). They have been described worldwide
with a variable prevalence of 1% in Europe and Japan (3, 5) and likely higher rates in
Asia and the Middle East, with a rate of 37% estimated in a monocentric study in Saudi
Arabia (6). However, few data exist for Africa. A rate of 18% of RMTases has been
identiﬁed in Algeria among ESBL enterobacterial producers (7). In addition, RmtB was
recently identiﬁed in sporadic enterobacterial isolates recovered in Angola and Kenya
in association with the blaNDM-1 gene (8, 9).
In 2015, we conducted a study to evaluate the occurrence of carbapenemase genes
among enterobacterial isolates recovered from hospitalized children in Angola, and we
identiﬁed a series of isolates harboring blaOXA-181 (carried by IncX3-type plasmids) or
blaNDM-1 (carried by IncA/C- or IncL/M-type plasmids) (8) carbapenemase genes. In view
of the very high rate of carbapenemase producers identiﬁed there, we wondered
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whether Angola might also be a reservoir of pan-AG resistance determinants, particu-
larly RMTase producers.
We recently developed the ﬁrst culture medium for selecting pan-AG-resistant
bacteria, mainly corresponding to RMTase producers. This so-called Superaminoglyco-
side medium has been validated on a collection of AG-resistant and -susceptible
reference strains (10). Our objective was therefore to perform a prospective evaluation
for screening RMTase producers using this novel selective medium. Our study was
performed using a pediatric population from a hospital in Angola, where the preva-
lence of carbapenemase producers is known to be high (8).
Children included in this study were hospitalized in different departments in the
main pediatric hospital of Luanda, Angola, in January 2017. Rectal swabs were collected
from 36 patients. Each sample was cultured overnight in Luria-Bertani (LB) broth. One
calibrated inoculated loop (10 l) of each sample was plated onto the Superaminogly-
coside medium consisting of eosin-methylene blue agar (EMB) 3.75%, gentamicin 30
g/ml, amikacin 30 g/ml, vancomycin 10 g/ml, and amphotericin B 5 g/ml to select
for AG-resistant Gram-negative isolates (10). In addition, selection of carbapenem-
resistant isolates was performed using the Supercarba selective medium to select for
carbapenem-resistant isolates (11). Once selected, the carbapenem-resistant isolates
were tested by Carba NP to detect for carbapenemase producers (12). Finally, we
included in our screening a search for colistin-resistant Enterobacteriaceae by using the
Superpolymyxin selective medium (13). For all selected isolates, identiﬁcation at the
species level was performed with the API20E system (bioMérieux, La Balme-les-Grottes,
France). Antimicrobial susceptibility testing was performed and interpreted according
to the disk diffusion method following CLSI recommendations (14). Polymyxin suscep-
tibility was performed by the broth microdilution method as recommended by EUCAST
(www.eucast.org). Identiﬁcation of the ESBL and carbapenemase genes, the aminogly-
coside resistance 16S rRNA methylase genes, the qnr-type quinolone resistance genes,
and the polymyxin resistance mcr-like genes was performed by PCR as described
previously (15–19), followed by sequencing of the amplicons.
The main procedure and the main results obtained from our prospective screening
are summarized in Fig. 1.
Out of the 36 patients from whom rectal swabs were taken, 22 distinct isolates were
recovered from 20 different patients onto the Superaminoglycoside medium. In accor-
dance with the high speciﬁcity of this selective medium, they all displayed a high level
of resistance to the four AGs tested by the disk diffusion method (i.e., amikacin,
tobramycin, kanamycin, and gentamicin) and were found to be positive by the rapid
aminoglycoside NP test (20).
PCR and sequencing were performed to identify RMTase-encoding genes (Table 1).
Surprisingly, all 22 isolates tested positive for an RMTase gene. A total of 16 isolates
harbored the rmtB gene (9 Escherichia coli, 5 Klebsiella pneumoniae, 1 Enterobacter
cloacae, and 1 Enterobacter aerogenes), 5 harbored the armA gene (2 K. pneumoniae, 1
E. aerogenes, 1 E. cloacae, and 1 Citrobacter freundii), and a single K. pneumoniae
harbored the rmtC gene (Table 1). None of the strains carried two different RMTase-
encoding genes.
All of the pan-AG isolates were resistant to broad-spectrum cephalosporins, and 10
of the 22 isolates were resistant to carbapenems. In addition, all of these isolates were
resistant to ﬂuoroquinolones. PCR ampliﬁcation followed by sequencing was used to
identify coresistance determinants and showed that 15 isolates produced the ESBL
CTX-M-15, 2 isolates produced the ESBL CTX-M-55, and 10 isolates produced the NDM-5
carbapenemase (Table 1). In addition, the plasmid-mediated quinolone resistance gene
qnrB was identiﬁed in 16 isolates (Table 1).
To characterize the plasmids bearing the RMTase genes, conjugation assays were
performed, followed by PCR-based replicon typing (PBRT), Kieser extraction, and gel
electrophoresis to evaluate the plasmid sizes (21, 22). In addition, IncX3-type replicons
were searched by using speciﬁc primers as described previously (8). Azide-resistant E.
coli J53 was used as a recipient for mating-out assays. Transconjugants were selected
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on LB agar plates supplemented with sodium azide 100 g/ml, gentamicin 50 g/ml,
and amikacin 50 g/ml. The rmtB gene was carried, in most cases, by a conjugative
125-kb IncFIB plasmid that also carried the blaTEM-1 penicillinase gene (10/16 isolates).
The other identiﬁed rmtB-positive plasmids belonged to IncL/M, IncN, and IncY incom-
patibility groups, which carried blaCTX-M-15, blaCTX-M-55, and blaNDM-5, respectively (Table
1). The armA gene was carried by a conjugative IncA/C plasmid, associated with the
blaNDM-5 carbapenemase gene for three of the ﬁve isolates harboring this gene. Even
though transconjugants could be obtained, the incompatibility group of the plasmid
bearing the rmtC gene could not be determined by PBRT, suggesting that the genetic
background of this plasmid corresponded to one that was uncommon.
Clonality of the different RMTase-producing E. coli and K. pneumoniae isolates was
investigated by multilocus sequence typing (MLST), which showed highly diverse
genetic backgrounds for E. coli and K. pneumoniae isolates (Table 1). Noticeably, ST448
complex was the most frequently identiﬁed RmtB-producing E. coli clone (5/9).
By using the carbapenem-resistant selective medium followed by testing with Carba
NP, 57 carbapenemase-producing enterobacterial isolates were recovered from 28
patients, leaving only 8 patients free of carbapenemase producers. This rate of colo-
nization (78%) by carbapenemase-producing Enterobacteriaceae was much higher than
the rate found in a study we conducted in the same hospital 2 years earlier that
revealed a colonization rate of 36% (8).
The blaNDM-5 gene was identiﬁed in 24 isolates, the blaNDM-1 gene in 10 isolates, and
the blaOXA-181 gene in 23 isolates (Table 2). Four patients were colonized by the three
different carbapenemase producers. The emergence of NDM-5-producing isolates was
FIG 1 Flow diagram illustrating the procedure and results for the prospective screening of 16S rRNA
methylase producers, carbapenemase producers, and colistin-resistant isolates using the Superaminogly-
coside, Supercarba, and Superpolymyxin selective media, respectively.
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noticed, whereas only a few NDM-1 and most OXA-181 producers were recovered in
our previous study (8).
Among the NDM-producing isolates were 14 K. pneumoniae isolates producing
NDM-1 or NDM-5 (8 and 6 isolates, respectively) and 15 E. coli isolates producing
NDM-5, among which 4 isolates coproduced RmtB (Table 2). The other species identi-
ﬁed were E. cloacae (2 NDM-1 and 2 NDM-5 positive) and a single NDM-5-producing C.
freundii. The 24 OXA-181 producers included 10 K. pneumoniae, 8 E. coli, 4 E. cloacae,
and 1 E. aerogenes; and the blaOXA-181 gene was located on an 30-kb IncX3 plasmid
in 20 isolates, as found previously (8). Transformation experiments using E. coli TOP10
as the recipient were performed for the 4 IncX3-negative OXA-181 producers, identi-
fying the blaOXA-181 gene on a 60-kb untypeable plasmid that did not carry any other
resistance determinant. Two NDM-5 and 3 NDM-1 producers were also transformed.
Most often, the blaNDM-1 gene was carried by an 60-kb untypeable plasmid cohar-
boring qnrS and blaCTX-M-15, whereas the blaNDM-5 gene was located on an 50-kb
IncX3 plasmid (Table 2).
MLST analysis showed a predominance of the ST147 clone among the NDM-1-
positive K. pneumoniae isolates (7/8) and the ST10 clone among the NDM-1-positive E.
coli isolates (9/15). Six different E. coli and 8 different K. pneumoniae clones were
identiﬁed among the OXA-181 producers.
Note that no enterobacterial isolate exhibiting acquired resistance to colistin was
detected.
We report here a high rate of recovery of 16S RMTase and carbapenemase producers
in this population of hospitalized children in Angola, colonizing 56% and 78% of the
patients, respectively. The high rate of identiﬁcation of 16S RMTase producers is of
concern in the context of endemicity of carbapenemases.
TABLE 1 Genetic features associated with the 16S RMTase-producing isolates
Strain Species ST Resistance determinantsa
Plasmid
incompatibilityb
Plasmid
size (kb)c Resistance phenotyped
R21 E. coli ST448 rmtB, bla TEM-1, blaCTX-M-15, qnrB IncFIB 95 CAZ, SXT, TET, NAL, GEN, AMK
R23 E. coli ST10 rmtB, blaTEM-1, blaNDM-5,
blaCTX-M-15
IncFIB 95 CAZ, IMP, SXT, TET, NAL, GEN, AMK
R24 E. coli ST10 rmtB, blaTEM-1, blaNDM-5 IncFIB ND CAZ, IMP, SXT, TET, NAL, GEN, AMK
R31r E. coli ST448 rmtB, blaTEM-1, blaNDM-5,
blaCTX-M-15, qnrB
IncFIB 125 CAZ, IMP, SXT, TET, NAL, GEN, AMK
R46 E. coli New ST rmtB, blaTEM-1, blaNDM-5,
blaCTX-M-15
IncY 125 CAZ, IMP, SXT, NAL, GEN, AMK
R49 E. coli ST448 rmtB, blaTEM-1, blaCTX-M-15, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R52 E. coli ST448 rmtB, blaTEM-1, blaCTX-M-15, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R57r E. coli ST448 rmtB, blaTEM-1, blaCTX-M-15, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R62 E. coli New ST rmtB, blaTEM-1, blaCTX-M-55 IncN 54 CAZ, SXT, TET, NAL, GEN, AMK
R28 K. pneumoniae ST273 rmtB, blaTEM-1, blaNDM-5,
blaCTX-M-15, qnrB
ND ND CAZ, IMP, SXT, TET, NAL, GEN, AMK
R30 K. pneumoniae ST147 rmtB, blaTEM-1, blaCTX-M-15, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R39 K. pneumoniae ST307 armA, blaNDM-5, blaCTX-M-15,
qnrB
IncA/C 154 CAZ, IMP, SXT, TET, NAL, GEN, AMK
R40 K. pneumoniae ST307 armA, blaTEM-1, blaCTX-M-15, qnrB IncA/C ND CAZ, SXT, TET, NAL, GEN, AMK
R45 K. pneumoniae ST147 rmtB, blaTEM-1, blaCTX-M-55, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R48 K. pneumoniae ST273 rmtC, blaNDM-5, blaCTX-M-15, qnrB ND 125 CAZ, IMP, SXT, TET, NAL, GEN, AMK
R57b K. pneumoniae ST101 rmtB, blaTEM-1, blaCTX-M-15, qnrB IncL/M 66 CAZ, SXT, GEN, AMK
R69 K. pneumoniae ST36 rmtB, bla-TEM-1, qnrB ND 190 CAZ, SXT, TET, GEN, AMK
R31b E. aerogenes ND rmtB, blaTEM-1, blaCTX-M-15, qnrB IncFIB 125 CAZ, SXT, TET, NAL, GEN, AMK
R50 E. aerogenes ND armA, blaNDM-5, qnrB IncA/C 154 CAZ, IMP, SXT, TET, GEN, AMK
R72 E. cloacae ND armA, blaNDM-5 IncA/C 135 CAZ, IMP, SXT, GEN, AMK
R79 E. cloacae ND rmtB, blaTEM-1, blaCTX-M-15 IncFIB 110 CAZ, SXT, GEN, AMK, TOB
R8 C. freundii ND armA, blaTEM-1, blaNDM-5,
blaCTX-M-15, qnrB
IncA/C ND CAZ, IMP, SXT, TET, NAL, GEN, AMK
aUnderlined resistance genes are colocated with the RMTase-encoding gene.
bND, not determinable by the PBRT method.
cPlasmid size of the plasmid carrying the RMTase-encoding gene. ND, not determined because of plasmid degradation on electrophoresis gel.
dCAZ, ceftazidime; IMP, imipenem; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; NAL, nalidixic acid; GEN, gentamicin; AMK, amikacin; TOB, tobramycin.
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TABLE 2 Genetic features associated with carbapenemase-producing isolates
Strain Species STa Resistance determinantsb
Plasmid
incompatibility
Plasmid
size (kb)c Resistance phenotyped
CR23r E. coli ST10 blaNDM-5, blaCTX-M, rmtB IncX3 55 CAZ, ETP, IMP, NAL, TET, GEN, AMK, TOB
OR24 E. coli ST10 blaNDM-5, blaTEM-1, rmtB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, AMK, TOB
CR28 E. coli New ST blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN
CR31r E. coli ST10 blaNDM-5, blaCTX-M, rmtB IncX3 60 CAZ, ETP, IMP, NAL, TET, GEN, AMK, TOB
CR39r E. coli ST10 blaNDM-5, qnrB IncX3 60 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR40 E. coli ST10 blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR44 E. coli ST10 blaNDM-5, qnrB IncX3 50 CAZ, ETP, IMP, NAL, TET, TOB
CR47r E. coli ND blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, TOB
CR48r E. coli ST2083 blaNDM-5, blaCTX-M IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR50r E. coli ST448 blaNDM-5, qnrS IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR52r E. coli ST10 blaNDM-5, rmtB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, AMK, TOB
CR57r E. coli New ST blaNDM-5, blaCTX-M IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
OR62 E. coli ND blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, GEN, AKN, TOB
CR74 E. coli ST10 blaNDM-5, blaCTX-M IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR79 E. coli ST10 blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
OR9r E. coli New ST blaOXA-181, qnrS, qnrB IncX3 60 ETP, NAL, TET, GEN, TOB
OR26r E. coli New ST blaOXA-181, qnrS, blaCTX-M IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR39r E. coli New ST blaOXA-181, qnrS, qnrB IncX3 60 ETP, NAL, GEN, TOB
OR45r E. coli ST448 blaOXA-181, blaCTX-M IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR46r E. coli ST448 blaOXA-181, blaCTX-M IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR47r E. coli ST448 blaOXA-181, blaCTX-M IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR78 E. coli New ST blaOXA-181, qnrS IncX3 60 ETP, TET
OR79 E. coli New ST blaOXA-181, qnrS IncX3 60 ETP, NAL
CR2 K. pneumoniae ST1031 blaNDM-5, blaCTX-M-like, qnrB IncX3 50 CAZ, ETP, IMP, TET
CR9 K. pneumoniae ST414 blaNDM-5, blaCTX-M, qnrB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR21 K. pneumoniae ST2602 blaNDM-5, blaCTX-M, qnrB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR23b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, AMK, TOB
CR25 K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, AMK, TOB
CR30b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 60 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR31b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 60 CAZ, ETP, IMP, NAL, AMK, TOB
CR39b K. pneumoniae ST2602 blaNDM-5, blaCTX-M IncX3 60 CAZ, ETP, IMP, NAL, TET, GEN I, TOB
CR47b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, AMK, TOB
CR48b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, AMK, TOB
CR50b K. pneumoniae ST414 blaNDM-5, qnrB IncX3 50 CAZ, ETP, IMP, GEN, TOB
Cr60 K. pneumoniae ST11 blaNDM-1, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR69 K. pneumoniae ST11 blaNDM-5, blaCTX-M, qnrB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR79b K. pneumoniae ST147 blaNDM-1, blaCTX-M, qnrS IncFIA 60 CAZ, ETP, IMP, NAL, AMK, TOB
OR3 K. pneumoniae ST11 blaOXA-181, qnrB, blaCTX-M IncX3 60 CAZ, ETP, TET, GEN, TOB
OR9b K. pneumoniae ST1214 blaOXA-181 IncX3 60 ETP
OR26b K. pneumoniae ST2092 blaOXA-181, qnrS, qnrB, blaCTX-M IncX3 60 CAZ, ETP, NAL, TOB
OR30 K. pneumoniae ST466 blaOXA-181, qnrS, blaCTX-M, qnrB IncX3 60 CAZ, ETP, TET, GEN, TOB
OR31 K. pneumoniae ST976 blaOXA-181, qnrS, blaCTX-M IncX3 60 CAZ, ETP, TET
OR39b K. pneumoniae ST11 blaOXA-181, qnrS, qnrB, blaCTX-M IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR47b K. pneumoniae New ST blaOXA-181, qnrS, qnrB, blaCTX-M IncX3 60 CAZ, ETP, TET, GEN, TOB
OR50 K. pneumoniae ST26 blaOXA-181, qnrS, qnrB, blaCTX-M IncX3 60 CAZ, ETP, GEN, TOB
OR52b K. pneumoniae New ST blaOXA-181, qnrS, blaCTX-M IncX3 60 CAZ, ETP, GEN, TOB
OR57 K. pneumoniae ST2092 blaOXA-181, qnrS, qnrB, blaCTX-M IncX3 60 CAZ, ETP, GEN, TOB
CR3 E. cloacae ND blaNDM-1, qnrB IncFIA 100 CAZ, ETP, IMP, NAL, TOB
CR45 E. cloacae ND blaNDM-1, blaCTX-M, qnrS IncFIA 100 CAZ, ETP, IMP, NAL, AMK, TOB
CR52b E. cloacae ND blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
CR57b E. cloacae ND blaNDM-5 IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
OR2 E. cloacae ND blaOXA-181, blaCTX-M, qnrS, qnrB IncX3 60 CAZ, ETP, GEN, AMK, TOB
OR45b E. cloacae ND blaOXA-181, qnrS, qnrB IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR48 E. cloacae ND blaOXA-181, qnrS IncX3 60 CAZ, ETP, NAL, TET, GEN, TOB
OR60 E. cloacae ND blaOXA-181 IncX3 60 CAZ, ETP, GEN, TOB
OR72 E. aerogenes ND blaOXA-181, qnrB IncX3 60 CAZ, ETP, TET, GEN, TOB
CR52v C. freundii ND blaNDM-5, blaCTX-M, qnrB IncX3 50 CAZ, ETP, IMP, NAL, TET, GEN, TOB
aND, not determinable.
bUnderlined resistance genes are colocated with the carbapenemase-encoding gene.
cSize of the plasmid carrying the carbapenemase-encoding gene.
dCAZ, ceftazidime; ETP, ertapenem; IMP, imipenem; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; NAL, nalidixic acid; GEN, gentamicin; AMK, amikacin; TOB,
tobramycin.
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It is worth highlighting that our methodological approach may explain this high
detection rate. Our study was prospective, using the ﬁrst screening medium developed
to select for pan-AG-resistant Enterobacteriaceae, previously shown to exhibit excellent
sensitivity. Therefore, the high rate in this study compared with those found in the
literature might be the result of a very sensitive screening methodology for 16S RMTase
producers. We may speculate that the global prevalence of 16S RMTase producers is
largely underestimated worldwide and that the Superaminoglycoside selective me-
dium will be an excellent tool for better assessment of the real extent of the problem.
Another concern that came out of the present study is the occurrence of NDM-5
producers, which were not identiﬁed in our previous study performed a year earlier in
the same hospital (8). It has been shown that NDM-5 possesses a higher hydrolytic
capacity than NDM-1 toward carbapenems and confers higher resistance levels to those
molecules (23). Therefore, we can speculate that the carbapenem selective pressure
may be responsible for a switch from NDM-1 producers to NDM-5 producers in that
geographic area. Interestingly, the blaNDM-5 gene was associated with an IncX3 plasmid,
as previously reported in different European countries, Australia, Algeria, India, and
China (23, 24). This plasmid type seems to play an important role in the horizontal
transfer of the carbapenemase gene among enterobacterial isolates and has been
found to be associated with the spread of both blaNDM and blaOXA-181 genes in our
study. Note that our study identiﬁed NDM-1-producing K. pneumoniae ST147 as a
source of nosocomial dissemination, as previously reported in China and recently in
Tunisia and Algeria (25, 26). Therefore, this clone appears to be widespread on the
African continent and elsewhere, and implementation of surveillance and control
studies should be reinforced to prevent its massive dissemination.
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